Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors

NCT07558473 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-08-07

No results posted yet for this study

Summary

The goal of this study is to learn if an online computerized training program improves processing speed, attention, and working memory in children with a primary brain tumor during and after active cancer treatment. The main questions it aims to answer are:

1. Is the cognitive intervention feasible to administer to children with brain tumors during and after cancer treatment?,
2. Is the cognitive intervention acceptable to children and caregivers?, and
3. Does the cognitive intervention improve neuropsychological functioning?

There is no comparison group for this study.

Participants will:

1. Complete an online computerized cognitive training program for approximately 15 minutes per day, 5 days a week, for 8 weeks;
2. Have weekly check-ins with the cognitive coach,
3. Complete a survey at the end of the cognitive training program, and
4. Complete pre- and post- neuropsychological testing.

Conditions

  • Brain Tumor, Pediatric

Interventions

BEHAVIORAL

Online computerized cognitive training intervention focused on processing speed.

This online cognitive training program aims to improve processing speed through computerized cognitive exercises. Participants will complete approximately 15 minutes of training, 5 days per week for 8 weeks. Weekly check-ins with a cognitive coach will assist with engagement and problem solve any barriers.

Sponsors & Collaborators

  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    lead OTHER

Principal Investigators

  • Rachel K Peterson, PhD · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-30
Primary Completion
2031-07-30
Completion
2033-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07558473 on ClinicalTrials.gov